DEVELOPMENTAL REGULATION IN ANTHER TISSUE OF PLANTS

Abstract: The present invention relates generally to the use of genetic engineering to induce developmental regulation in anther tissue of plants, and more particularly to induce nuclear male sterility, and to genetic sequences useful for same. More particularly, the present invention relates to the identification of a genomic clone and promoter capable of tissue- and development-specific expression which provides a means of tissue and developmental regulation in plants and more specifically a means of producing nuclear male sterile plants. Even more particularly, the present invention provides a genomic clone having a nucleotide sequence as set forth in SEQ ID NO.1 or homologous sequences thereof such as the nucleotide sequence as set forth in SEQ ID NO.3.

Description: DEVELOPMENTAL REGULATION IN ANTHER TISSUE OF PLANTS The present invention relates generally to the use of genetic engineering to induce developmental regulation in anther tissue of plants, and more particularly to induce nuclear male sterility, and to genetic sequences useful for same. Nucleotide and amino acid sequences are referred to herein by sequence identity numbers (SEQ ID NOs) which are defined after the bibliography. A general summary of the SEQ ID NOs is provided before the examples. Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers. Anther-specific genes are those genes that are expressed exclusively in the male reproductive tissues, rather than "house-keeping" genes which are active in all plant cells. Anther-specific genes play an important role in pollen development and, hence, in the control of seed production. Differentiation and development of the male gametophyte of angiosperms, the pollen grain, depends partly upon transcription of the haploid genome following meiosis (Mascarenhas, 1988). The study of these coordinated events at the molecular level has been considered important in order to understand the developmentally specific regulation and functions of pollen-expressed genes. In this regard, Theerakulpisut g_t al (1991) studied gene expression in pollen of Brassica campestris. By differential screening of a mature B. campestris pollen cDNA library, an anther-specific clone, designated Bcpl, was isolated. In work leading up to the present invention, the inventors undertook a detailed investigation of Bcpl expression with the aim of isolating a genomic clone and to sub-clone and characterise the 5' upstream regulatory regions of the genomic clone. It has been surprisingly discovered that the genomic clone of Bcpl, i.e. Bgpl, is tissue and developmentally specific thereby providing a means to enable tissue and developmental regulation in plants and in particular to produce nuclear male sterile plants. It has further been discovered that the Bgpl gene from B. campestris represents a family of homologous genes from a diverse range of plants. Byway of shorthand notation, a genomic clone is referred to herein by the genus and/or species of the plant from which it is isolated followed by the term 'Bgpl". A cDNA clone is referred to in similar fashion except using the term "Bcpl". Accordingly, one aspect of the present invention contemplates a genomic DNA isolate comprising: (i) all or part of a gene or related genetic sequence preferentially expressed in anther tissue of a plant and substantially not expressed in non-anther tissue; and (ii) an open reading frame having a nucleotide sequence as set forth in SEQ ID NO. 1: ATG GGT CGC CAA AAC GCT GTC GTA GTT TTT GGC CTT GTG TTC TTG GCC ATC CTT GGC CTC GCC GCA GCT GCC TCC TCT CCG TCT CCT TCA GCG TCA CCC TCC AAA GCT CCG GCT GCT ACC GTA ACC GAT GTC GAA GCT CCA GTG AGC GAG GAC ACC ATT GGA ACC ACC GAT GAC GAT GCA GCT GCT TCT CCA GGT GAT GGT GAC GTA GCT GTG GCT GGT CCT CTA GGA AGT GAC TCC TCC TAC GGT AGT AAT GGA CCT TCA CCT TCT ACT GAT GCT GCT GAC AGC GGC GCG CCT GCT CTT GGC GTC TCT GCG GTC TTC GTT GGT GTT GCA TCC ATC GCC GGT TCT TTC TTG TTT CTC or having at least 20% similarity to all or part thereof. The deduced amino acid sequence to the open reading frame defined in SEQ ID NO. 1 is shown in SEQ ID NO. 2. The expression "gene or related genetic sequence" is used in is broadest sense and includes any contiguous series of nucleotides constituting an open reading frame. Generally, an open reading frame comprises at least 48 contiguous nucleotides arranged into triplets without interuption by a stop codon. A nucleotide sequence having at least 20% similarity to all or a portion of SEQ ID NO. 1 is referred to herein as a "homologous gene". Preferably, there is at least 20% similarity to the entire SEQ ID NO. 1 sequence. Even more preferably, there is at least 30% similarity, still more preferably at least 45% similarity, even still more preferably at least 55-60% similarity, yet even still more preferably at least 75-95% similarity to all or part of SEQ ID NO. 1. A "part" in this context is a contiguous series of at least 20 nucleotides in SEQ ID NO. 1. Preferably, the genomic DNA isolate is a dicotyledonous plant such as tomato, corn, rice, wheat, raddish, tobacco and oil seed rapes. Particularly preferred plants are Brassica species, Arabidopsis species and Nicotiana species. In a most preferred embodiment, the plant is Brassica campestris and the genomic DNA isolate has an open reading frame with a sequence as set forth in SEQ ID NO. 1. A preferred homologous gene having at least 20% nucleotide similarity to SEQ ID NO. 1 is from Arabidopsis thaliana comprising an open reading frame with a nucleotide sequence as set forth in SEQ ID NO. 3: ATG GGT CGC CAA AAC ATT GTC GTC GTG GTT GCC CTC GTC TTC ATC CGG ATC ATT GGC CTT GCC GCA GCT GCC TCC TCT CCA TCT CCT TCA GCG TCT CCC TCC AAA GCT CCA GCT GCC TCC AAA ACC GAT CAT GTC GAG GCT CCA GTC ACC GAT GAC CAA ATC GGA ACC ACC GAT GAC GAT GCA GCT CCT ACT CCT GGT GAC GGT GAC GTT GCA GTG GCT GGT CCT CTA GGA AGT GAC TCC TCG TAC GAC AAT GCC GCT ACA GGC TCT GCT GAT TCT GCC AAA AGC GGT GCG GCA GCT CTT GGC GTC TCT GCG GTC GTC GTT GGT GTT ACA TCA TTG CTG GTT CTT TCT TGT TAC TCA AGT TGG GCA TTG TTT TAT GAT AAG AAG GTT ATT TTA AAC GAA GAT TAT TAT ATG The deduced amino acid sequence of SEQ ID NO. 3 is defined in SEQ ID NO. 4. Another aspect of the present invention provides a genomic DNA isolate as defined above and further comprising a promoter region 5' to the open reading frame, wherein said promoter region: (i) is capable of directing expression in taptum and/or pollen tissue; and (ii) comprises a nucleotide sequence as set forth in SEQ ID NO. 5: TATCATTCCT TTAATTTCAA GGAATTATAG AACAAAAAAT GTTCTTTATA AAAATTAAGA AGGAACAAGG GATTCATTCC TACTATTCTG TTCTTGGTCA TTATTTTCCT CTTCATTCAT ATTGTTTCTT TAATTGTTAC CAATTAGAAC TTTAACGAAT AAATAGTTAA TTCGTATTAT GAGATTTACA CAATTCTTAT TCACTCAATT TGGAGTTTTA AAGATTTTTT AAAAGATTTA TGGTGGGAAC CTTCTTCTTT TCTTATTTAT CATGATGATG ATAACCTTCC CAGCAGAATT ATTCTTAGAA CTTTTTTTCA CATTTAGGTA TCCATGCCTA AGTAAGGCTT AGTTAAAGAT GTTTTATAAA CTTTGATCAA AATATTCATT CAATTAATTT GAGCTTCAAC TATAAATTGT TGTATGCATT CGTTTTAGCC TGTAAGATAT CAGACATTCA CGTTTCGATA AACAAGTATA TAAATAATAT GAATATTGTA CATTCATTTT ATTCGGTTCA TCAACCAAAA AAAATAAAAA TAAATATTCG TATTCATCTA TGCTTTGGCA TGGTCCGTTC TTTTTTCTTG ATTGGCTCGT TACCATTCAA AAATATATAC CTTAGCAAAC CCATTTTTAG ACATTCCAGT TGATCTACAT TAGATTGAAC GGTATTCCTC CTACGTAGTA AGAACGTTTT CTATTTTTCT TTGTTTCAGT CATACAACAC AACTATATAT ACACAGCAAC CCCATCTCCT CTCCAATCAT CACAATCTCT AACGTTAAAC CCTAAGACAA ACTAAAAGAG AGCTACGTAC AAGGAGACAG AGAGAAGA or having at least 20% similarity to all or part thereof. Preferred promoters comprise the promoter defined in SEQ ID NO. 5 and the promoter defined in SEQ ID NO. 6 which has the following nucleotide sequence: AAAAGCGAGA AGAAGAAGTC TGGAAGATTT GAGAGCTTAA AGTGGTCGAG TGTAAAACCC TAACTCGCTG TTGATGGCAG AATCGTAAAT CGGAATTGAT TCATGGGCCT AACAAGACGT • TTGGGCTTAT GGGTTTAAAG CCCATCTGAT ATAAGATGAA TAGAATGTTC ATGGCAATAC TATCATAATT TGGTTCTTTA ATAAGACACT CGTTAATACG ACGACGATTT GAAGTTGAAC GAATGTTTTC ATATTCATTC GCATGTTCAC CAATCAAAAT CTATATCTGA ACAAGTCCAT TTTTAGGTAC TCCAGTAGAT TTACATTGGA TTGTAAGGTA ATCCTACATC TTAGTTCACG TTTTCTATTT TTGGTCTTGT CACTAAACAC AACTATATAT ACATATCAAA CTCATCTTCG GAAATCATCA CAATCAATAA ACCTCAAACC CTAAAATAAA TTAAACGAGT TCTACGTAAG AAGGAGAGAG AGAAGA Yet another aspect of the present invention relates to a genomic DNA isolate comprising: (i) all or part of a gene or related genetic sequence preferentially expressed in anther tissue of a plant and substantially not expressed in non-anther tissue; (ii) a promoter region capable of directing expression in tapetum and/or pollen tissue; (iii) a nucleotide sequence substantially as set forth in SEQ ID NO. 7 : TATCATTCCT TTAATTTCAA GGAATTATAG AACAAAAAAT GTTCTTTATA AAAATTAAGA AGGAACAAGG GATTCATTCC TACTATTCTG TTCTTGGTCA TTATTTTCCT CTTCATTCAT ATTGTTTCTT TAATTGTTAC CAATTAGAAC TTTAACGAAT AAATAGTTAA TTCGTATTAT GAGATTTACA CAATTCTTAT TCACTCAATT TGGAGTTTTA AAGATTTTTT AAAAGATTTA TGGTGGGAAC CTTCTTCTTT TCTTATTTAT CATGATGATG ATAACCTTCC CAGCAGAATT ATTCTTAGAA CTTTTTTTCA CATTTAGGTA TCCATGCCTA AGTAAGGCTT AGTTAAAGAT GTTTTATAAA CTTTGATCAA AATATTCATT CAATTAATTT GAGCTTCAAC TATAAATTGT TGTATGCATT CGTTTTAGCC TGTAAGATAT CAGACATTCA CGTTTCGATA AACAAGTATA TAAATAATAT GAATATTGTA CATTCATTTT ATTCGGTTCA TCAACCAAAA AAAATAAAAA TAAATATTCG TATTCATCTA TGCTTTGGCA TGGTCCGTTC TTTTTTCTTG ATTGGCTCGT TACCATTCAA AAATATATAC CTTAGCAAAC CCATTTTTAG ACATTCCAGT TGATCTACAT TAGATTGAAC GGTATTCCTC CTACGTAGTA AGAACGTTTT CTATTTTTCT TTGTTTCAGT CATACAACAC AACTATATAT ACACAGCAAC CCCATCTCCT CTCCAATCAT CACAATCTCT AACGTTAAAC CCTAAGACAA ACTAAAAGAG AGCTACGTAC AAGGAGACAG AGAGAAGAAT GGGTCGCCAA AACGCTGTCG TAGTTTTTGG CCTTGTGTTC TTGGCCATCC TTGGCCTCGC CGCAGCTGCC TCCTCTCCGT CTCCTTCAGC GTCACCCTCC AAAGCTCCGG CTGCTACCGT AACCGATGTC GAAGCTCCAG TGAGCGAGGA CACCATTGGA ACCACCGATG ACGATGCAGC TGCTTCTCCA GGTGATGGTG ACGTAGCTGT GGCTGGTCCT CTAGGAAGTG ACTCCTCCTA CGGTAGTAAT GGACCTTCAC CTTCTACTGA TGCTGCTGAC AGCGGCGCGC CTGCTCTTGG CGTCTCTGCG GTCTTCGTTG GTGTTGCATC CATCGCCGGT TCTTTCTTGT TTCTCTGAGG TGTGTATTAT CATGAGAAGA TTATTCTGAC TGAAGACTAT TAATATGTAT GGATGATTGT GATGGTCGTG TTGTAATATG TTTCTCCTTT ATTGTGAGAA ACGATGTTTT GCTAATAAAA CTGAAAAAAA AAACGAAAAT TTCCTCTAGC CAAGGATAAA ATGCCGGAAT TGCGGATTAA ATAGTACTAT TCAATCCTTT CATGTTTTCG AGATACAAAA ATACATATTA ATCAGGTAGA GCCGTAGAAG TCCGTAACCA CTGGATACAA TCTTTTTCGT AGTAAGAAAG AAAGTACAAT CTTATTCTAA ATGCATGTGT TTGATAGATT ATGGAACGGT GAGAAGGGCA TTGATTATGG GAGTTATGAT CGAAGATACA CACGATACCA TCTTTTTAGG TATAGCTTCT TCTTCTATAA A or having at least 20% similarity to all or part thereof. In a preferred embodiment, the above genomic DNA isolate further comprises: (iv) a nucleotide sequence which is capable of hybridising under low stringency conditions to all or part of a nucleotide sequence substantially complementary to SEQ ID NO. 7. Most preferred genomic DNA isolates comprise SEQ ID NO. 7 and SEQ ID NO. 8, the latter which has the following nucleotide sequence: AAAAGCGAGA AGAAGAAGTC TGGAAGATTT GAGAGCTTAA AGTGGTCGAG TGTAAAACCC TAACTCGCTG TTGATGGCAG AATCGTAAAT CGGAATTGAT TCATGGGCCT AACAAGACGT TTGGGCTTAT GGGTTTAAAG CCCATCTGAT ATAAGATGAA TAGAATGTTC ATGGCAATAC TATCATAATT TGGTTCTTTA ATAAGACACT CGTTAATACG ACGACGATTT GAAGTTGAAC GAATGTTTTC ATATTCATTC GCATGTTCAC CAATCAAAAT CTATATCTGA ACAAGTCCAT TTTTAGGTAC TCCAGTAGAT TTACATTGGA TTGTAAGGTA ATCCTACATC TTAGTTCACG TTTTCTATTT TTGGTCTTGT CACTAAACAC AACTATATAT ACATATCAAA CTCATCTTCG GAAATCATCA CAATCAATAA ACCTCAAACC CTAAAATAAA TTAAACGAGT TCTACGTAAG AAGGAGAGAG AGAAGAATGG GTCGCCAAAA CATTGTCGTC GTGGTTGCCC TCGTCTTCAT CCGGATCATT GGCCTTGCCG CAGCTGCCTC CTCTCCATCT CCTTCAGCGT CTCCCTCCAA AGCTCCAGCT GCCTCCAAAA CCGATCATGT CGAGGCTCCA GTCACCGATG ACCAAATCGG AACCACCGAT GACGATGCAG CTCCTACTCC TGGTGACGGT GACGTTGCAG TGGCTGGTCC TCTAGGAAGT GACTCCTCGT ACGACAATGC CGCTACAGGC TCTGCTGATT CTGCCAAAAG CGGTGCGGCA GCTCTTGGCG TCTCTGCGGT CGTCGTTGGT GTTACATCAT TGCTGGTTCT TTCTTGTTAC TCAAGTTGGG CATTGTTTTA TGATAAGAAG GTTATTTTAA ACGAAGATTA TTATATGTAA GGATGATTGT GATGATCCGT TGACCTGCAG GTCGACCCAG ATCCGCCTAC CTTTCACGAG TTGCGCAGTT TGTCTGCAAG ACTCTATGAG AAGCTGATAA GAGATAAGTT TGCTCAACAT CTTCTCGGGC ATAAGTCCGG ACACCATGGC ATCACAGTAT CGAGATGACA GAGGCAGGGA GTGGGACAAA ATTGAAATCA AATGATCGAT TTTATTTTGG CT Still yet another aspect of the present invention contemplates an isolated nucleic acid molecule which is capable of hybridising under low stringency conditions to the genomic DNA isolates defined above. Preferred nucleic acid molecules comprise a complementary strand of all or part of SEQ ID NO. 1 or SEQ ID NO. 3. A "part" in this context includes an oligonucleotide. A further aspect of the present invention provides a genetic construct comprising: (i) a promoter region capable of directing expression of a nucleotide sequence when operably linked downstream thereof in tapetum and/or pollen tissue; and (ii) said promoter being capable of hybridising under low stringency conditions to a complementary strand of SEQ ID NO. 5. For the purposes of defining the level of stringency, reference can conveniently be made to Sambrook et al., Supra at pp 387-389 which is herein incorporated by reference where the washing step at paragraph 11 is considered high stringency. A low stringency is defined herein as being in 0.1-0.5% w/v SDS at 37-45 °C for 2-3 hours. Depending on the source and concentration of nucleic acid involved in the hybridisation, alternative conditions of stringency may be employed such as medium stringent conditions which are considered herein to be 0.25%-0.5% w/v SDS at > 45 β C for 2-3 hours or high stringent conditions as disclosed by Sambrook et al., Supra. In a further related embodiment, there is provided a nucleic acid isolate having a sequence of nucleotides comprising or a complementary sequence of nucleotides comprising SEQ ID NO. 5 or a promoter functional derivative, fragment, part, homologue or analogue thereof. The latter functional derivative and like molecules comprise at least 20% nucleotide sequence similarity to SEQ ID NO. 5. An example of a promoter having at least 20% nucleotide similarity to SEQ ID NO. 5 is the promoter from A. thalian Bgpl having the sequence set forth in SEQ ID NO. 6. In accordance with these and other aspects of the present invention, the term "promoter" is used in its most general sense and refers to any nucleotide sequence which binds RNA polymerase and directs same to a transcriptional start site whereupon a gene or other nucleotide sequence downstream of said promoter is transcribed. A nucleotide sequence "downstream" of the promoter is also said to be "relative" the promoter. The term "genetic construct" is used in its most broadest sense to include an isolated nucleic acid molecule comprising a sequence of nucleotides. Preferably, the promoter is from a Brassica species such as B. compestrisor from an Arabidopsis species such as A. thaliana. Preferably, the genetic construct is transformable and operable in dicotyledon plants and in particular a Brassica species, Arabidopsis species or a Nicotiana species. The genetic construct may be conveniently engineered so as to place an endonuclease restriction site in a region 3 ' of the promoter to thereby readily enable the insertion of nucleotide sequences downstream of the promoter for their transcription. Generally, the inserted restriction site is unique to the genetic construct or may be represented twice but separated by a length of nucleic acid to be deleted upon restriction digestion of the genetic construct and followed by insertion of the required nucleotide sequence to be transcribed. The genetic construct of the present invention may comprise solely the promoter and optionally a nucleotide sequence downstream thereof or, alternatively, may comprise additional nucleotide sequences constituting promoter regulatory region(s), transcribed sequence regulatory regions, a marker (eg. antibiotic resistance, chemical compound resistance or enzyme), autonomous replication region and/or genome integration sequence. The promoter may be the naturally occurring promoter or may be an active fragment or part thereof or a derivative, analogue or homologue of the promoter. By "derivative" is meant to include any single or multiple nucleotide deletion, insertion and/or substitution to the promoter nucleotide sequence, provided said derivative is still active in tapetum and /or pollen tissue. Manipulation of the nucleotide sequence at known predetermined sites or random mutagenesis are conveniently accomplished by any number of techniques including M13, transposon and/or oligonucleotide mutagenesis. Various techniques are described by Maniatis Homologues and analogues of the promoter include promoters having a nucleotide sequence having at least 20%, preferably at least 30% similarity, more preferably at least 45% similarity, still more preferably at least 55-60% similarity and even more preferably at least 75-95% similarity to the first mentioned promoter and which function in anther tissue. Most preferred promoters comprise the sequence SEQ ID NO. 5 or SEQ ID NO. 6. The promoter of the present invention is tissue specific for anther tissue. More particularly, the promoter is specific for tapetum and/or pollen tissue. However, this is not intended to exclude genetic constructs based on the promoter of the present invention but modified to be capable of expression in non-anther tissues. The nucleotide sequence down stream of the promoter might give rise to antisense RNA or may encode specific traits such as a "lethal gene" or a 'Toiler gene" to specifically render a pollen grain infertile or incapable of maturation. The nucleotide sequence may also encode a trait, for example, which renders the pollen grain more resistant to predator or pathogen attack. In one particular embodiment, the nucleotide sequence downstream of the promoter is a ribozyme capable of targetting a mRNA transcript corresponding to SEQ ID NO. 1 or SEQ ID NO. 3 or a homologous genetic sequence thereof. According to this latter embodiment, there is provided a ribozyme which comprises a hybridising region and a catalytic region wherein the hybridising region is capable of hybridising to at least part of a target mRNA sequence transcribed from a genomic Bgpl gene as hereinbefore defined wherein the catalytic region is capable of cleaving said target mRNA thereby substantially down regulating expression of said genomic DNA isolate. A ribozyme according to this aspect of the invention may also be a polyribozyme. Methods for the construction of ribozyme are conveniently disclosed in Haseloff and Gerlach (1988) and in International Patent Application No. WO89/05852. Preferably, the ribozyme is under the control of a Bgpl promoter as hereinbefore described. The present invention further extends to a hybrid genetic sequence comprising a ribozyme as hereinbefore described fused, linked or otherwise chemically bonded to one or more sequence of nucleotides which is/ are substantially antisense to all or part of SEQ ID NO. 1 or a homologous sequence (e.g. antisense to all or part of SEQ ID NO. 3). The antisense sequence may flank both sides of a ribozyme or may be located to one end of said ribozyme. Reference to a ribozyme in this context includes reference to a polyribozyme. A "substantially antisense" molecule is a molecule capable of hybridising under physiological conditions to the reference sequence (e.g. SEQ ID NO. 1 or SEQ ID NO. 3) to a sufficient extent to reduce translation of said target sequence into functional protein or which results in male sterility. The present invention is particularly exemplified using the promoter isolated from a genomic clone of Bcpl, the genomic clone being designated herein 'Εgpl", from Brassica species or non-Brassica species with similar acting promoters. Such other promoters are referred to herein as "homologous promoters" and include the promoter from the homologous gene A. thaliana Bgpl defined by SEQ ID NO. 6. Most of the Bgpl promoter is required for pollen expression and in particular nucleotide regions -580 to -767, -322 to -580 and -116 to -168 whereas the nucleotide region up to -116 is only required for tapetum expression. According to a preferred embodiment, the present invention provides an isolated nucleic acid molecule carrying a promoter capable of directing expression in tapetum and pollen tissue and comprising the following nucleotide sequence identified as SEQ ID NO. 5, including functional derivatives or homologues having at least 20% nucleotide similarity to all or a part thereof and/or which are capable of hybridising to a complementary strand thereof under at least low stringency conditions. According to another embodiment, there is provided an isolated nucleic acid molecule carrying a promoter capable of directing expression in pollen tissue but not tapetum, said nucleic acid molecule comprising the following nucleotide sequence identified as SEQ ID NO. 9: TATCATTCCT TTAATTTCAA GGAATTATAG AACAAAAAAT GTTCTTTATA AAAATTAAGA AGGAACAAGG GATTCATTCC TACTATTCTG TTCTTGGTCA TTATTTTCCT CTTCATTCAT ATTGTTTCTT TAATTGTTAC CAATTAGAAC TTTAACGAAT AAATAGTTAA TTCGTATTAT GAGATTTACA CAATTCTTAT TCACTCAATT TGGAGTTTTA AAGATTTTTT AAAAGATTTA TGGTGGGAAC CTTCTTCTTT TCTTATTTAT CATGATGATG ATAACCTTCC CAGCAGAATT ATTCTTAGAA CTTTTTTTCA CATTTAGGTA TCCATGCCTA AGTAAGGCTT AGTTAAAGAT GTTTTATAAA CTTTGATCAA AATATTCATT CAATTAATTT GAGCTTCAAC TATAAATTGT TGTATGCATT CGTTTTAGCC TGTAAGATAT CAGACATTCA CGTTTCGATA AACAAGTATA TAAATAATAT GAATATTGTA CATTCATTTT ATTCGGTTCA TCAACCAAAA AAAATAAAAA TAAATATTCG TATTCATCTA TGCTTTGGCA TGGTCCGTTC TTTTTTCTTG ATTGGCTCGT TACCATTCAA AAATATATAC CTTAGCAAAC CCATTTTTAG ACATTCCAGT TG including functional derivatives or homologues having at least 20% nucleotide similarity to all or a part thereof and/or which are capable of hybridising to a complementary strand thereof under at least low stringency conditions. A particularly important homologue is SEQ ID NO. 6 from A. thaliana. Preferably, the nucleotide sequence of SEQ ID NO. 5, SEQ ID NO. 9 or SEQ ID NO. 6 is modified by the introduction of a restriction endonuclease cleavage site to facilitate the insertion of an operably linked second nucleotide sequence downstream of the promoter. Preferably, the nucleotide sequence of the present invention form part of a vector. The identification of a tissue and developmentally dependent promoter enables the production of genetic constructs which can be used to generate transgenic plants having certain traits expressed or down regulated. For example, the function of the Bgpl gene can be conveniently disrupted using antisense RNA or a ribozyme. Conveniently, the cDNA clone Bcpl is inserted in the reverse orientation relative the Bgpl promoter. This construct, when introduced into a suitable host, produces antisense RNA which disrupts expression of the Bgpl gene. Although not intending to limit the present invention to any one theory of mode of action, it is possible the antisense RNA forms a duplex with Bgpl RNA to thereby prevent its translation. Transgenic plants carrying the particular construct are generally male sterile but female fertile. According to this aspect of the present invention there is provided an antisense construct: (i) which comprises a nucleic acid molecule comprising at least eight contiguous nucleotides; (ii) which is capable of hybridising under physiological conditions to all or part of SEQ ID NO. 1 or a homologous sequence thereof; and (iii) which, in use, is capable of down regulating expression of a plant Bgpl gene. In this context, a "homologous" sequence comprises a nucleotide sequence having at least 20% similarity to all or part of SEQ ID NO. 1 and which is a Bgpl gene. Preferably, the antisense construct is at least 20 nucleotides long. More preferably, the antisense construct is at least 50-100 nucleotides long. Even more preferably, the antisense construct is all or part of a plant Bcpl or Bgpl in reverse orientation relative a promoter. The term "down regulates" or similar expressions such as "down regulating" means a reduction in the amount of full length Bgpl mRNA as determined by hybridisation or extent of translation into a Bgpl product or, most conveniently, generation of substantially male sterile plants. Yet another aspect of the present invention contemplates a method for generating male sterile plants, said method comprising transforming a cell or group of cells of said plant with a genetic construct capable of directing expression of a nucleotide sequence having a deleterious effect on tapetum and/or pollen tissue, regenerating a transgenic plant from said transformed cells and growing and/or maintaining said transgenic plant under conditions to thereby having a deleterious effect on said tapetum and/ or pollen tissue resulting in said plant being substantially male sterile. In an alternative embodiment, there is provided a method for generating male sterile plants, said method comprising introducing into a cell or group of cells of said plant, a genetic construct comprising all or part of a Bgpl, said Bgpl having a nucleotide sequence substantially similar to an endogenous Bgpl of the plant and then regenerating a plant from said cells. This method is term "co-suppression". The introduced Bgpl may be with or without a promoter. By "substantially" similar is meant an exogenous Bgpl comprising 85-100% nucleotide sequence similarity to an endogenous Bgpl. Still yet another aspect of the present invention provides a transgenic male sterile plants such as those made by the above method. The present invention is further described by the following non-limiting Figures and Examples: Figure 1 is a schemmatic representation of the Bgpl gene from Brassica campestris. A. Partial restriction map of genomic clone Bgpl. Box represents the sequenced region. B. Nucleotide sequence of Bgpl (SEQ ID NO. 7) showing the coding region along with 5' flanking region and 3' flanking region; nucleotide numbering is relative to the start of the transcription at position number 1. The amino acid sequence of the putative Bgpl protein is shown (SEQ ID NO. 2). The TATA box and the ATG translational start codon are underlined. Nucleotides which differ between the sequences of Bgpl and Bcpl are indicated by asterisks above the sequence. Figure 2 is a photographic representation showing Bgpl expression pattern in different organs of B. campestris. RNA transcripts are detectable only in pollen. Total RNA isolated from leaves, stems, flower minus anther and pollen was fractionated on a denatured agarose gel (20μg per lane), transferred onto a nylon membrane and probed with a Bgpl specific oligonucleotide (based on the sequence between nucleotides 181-201; 5'-GGCTGCTACCGTAACCGATGT - 3' [SEQ ID NO. 10]) labelled with 32 P. Bgpl DNA and Bcpl DNA were also probed to verify the specificity of the oligonucleotide, hybridisation was only observed to DNA from the clone Bgpl as indicated. Figure 3 is a photographic representation of DNA gel blot analysis of genomic DNA isolated from B. campestris. Genomic DNA was digested with the restriction endonucleases EccRI, Hirύlll and BarriHI as indicated and probed with ^P-labelled Bcpl DNA. The position of Hirύϊll digested 1 DNA is indicated. Figure 4 is a photographic representation identifying the transcriptional start of the Bgpl gene. Primer extension and plasmid sequencing (G, A, T, C) were performed using a synthetic oligonucleotide with sequence 5 '-CGT1T1 GGCGACCCA-3 ' (SEQ ID NO. 11) which is complementary to nucleotides 22-36. The nucleotide sequence at the 5' end is reported. The arrow indicates the position of the major extension product. Figure 5 is a histochemical detection of GUS activity in transgenic Arabidopsis fii B) and tobacco (I-J). GUS activity is indicated by blue staining (Jefferson et al, 1986). A. mature flower showing the distributionof GUS activity. B, C longitudinal section of a flower bud containing anthers at early bicellular stages, showing high level of GUS activity in tapetum (arrow heads). D. cross section of a near mature another showing GUS activity in degenerating tapetum (arrow heads) and pollen. E. cross section of an anther from control unfransformed plants. F. cross section of a mature anther showing GUS activity in pollen, but not in other anther tissues. G. GUS staining in mature pollen. H. pollen of control unfransformed plants. I. mature pollen of transgenic tobacco. J. mature pollen of control untransformed tobacco. Figure 6 shows Bgpl 5' deletion fragments. Each of the fragments shown were fused to the GUS gene in the vector pBHOl and introduced into Arabidopsis thaliana. The full length promoter fragment pBC1.2 was also introduced into Nicotiana tabacum Next to each promoter fragment is the GUS expression pattern observed for each corresponding pBHOl construct in A. thaliana. Figure 7 is a working model showing the likely location of cis-acting DNA elements controlling the expression of the Bgpl gene in pollen and tapetum. A+ indicates this region has a positive effect on expression and - signified a negative effect. The term min signifies the minimal promoter region necessary for pollen expression. Figure 8 is a diagramatic representation showing Bgpl antisense construct. Figure 9 is a photographic representation of a comprison of B. campestris wild type (WT) and an antisense plant (AM) showing appearance of siliques. Figure 10 is a photographic representation showing tissue-specific expression of the ArabidopsisBgpl gene, (a) RNA gel bot analysis showing the differential expression in vegetative and reproductive tissues. The transcripts of approximately 700 bp were detected in flowers, but not in the vegetative tissues tested, (b) in situ hybridisation of flower sections with biotin-labelled antisense (top panel) and sense (bottom panel) Bgpl-specific riboprobes. Flowers at two different developmental stages were used. RNA-RNA hybridisation signal was detected as bright regions on the sections. In immature flowers, an intensive hybridisation signal is present in the microspores (Mi) and the intact tapetal cells (Tc). In mature flowers, a very strong signal is present in pollen (Po) whereas only low level of signal is present in the remnants of tapetal cells (Tc) due to self-degeneration. Total RNAs were isolated and used (15μg/lane) for the gel blot as described (Maniatis et al, 1989). The blot was hybridised with a ^-labelled probe derived from Brassica Bcpl cDNA clone. Flowers at relevant stages were collected, fixed and embedded in LR white resin for in situ hybridisation essentially as described (Theerakulpisut et al, 1991). Biotin-labelled sense and antisense riboprobes were generated by in vitro transcription from the Bcpl cDNA clone. Hybridisation signal was detected using colloidal gold (15 nm) conjugated rabbit anti-biotin antibody (1:15 dilution), followed by silver enhancement. Sections were viewed under dark field microscopy. Figure 11 is a representation of (a) the nucleotide (SEQ ID NO. 8) and translated amino acid sequence (SEQ ID NO. 4) of the ArabidopsisBgpl gene. The sequence was determined by a genomic clone. The transcriptional initiation site determined by primter extension analysis was underlined (Xu, 1992). The longest open reading frame extends for 411 bp and translated into a 137 amino acids, approximately 14K protein with a highly hydrophobic region at N-terminus. A highly conserved (73% sequence identity) promoter region of 167 nucleotides which extends immediately upstream from the transcriptional initiation site was shared by the homologous genomic clone, Bgpl from Brassica campestris. Figure 11(b) is a diagram showing sequence identity between Arabidopsis Bgpl gene and Brassic Bgpl gene. The genomic clone was isolated by screening an Arabidopsis thaliana ecotype Landsberg erecta genomic library using a probe derived from a homologous Brassica cDNA clone, Bcpl. DNA sequencing was performed by dideoxy chain termination method using T7 DNA sequencing kit (Pharmacia LKB). Specific oligonucleotide primers were used to obtain the complete sequence. Sequence analysis was performed using the Melbot/Angis. Figure 12 is a photographic representation of DNA and RNA gel blot analysis of antisense male sterile plants, (a) Detection of antisense insertions in the primary antisense transformants (T 0 ). Genomic DNAs from wild type (WT) and 4 individual antisense male sterile plants were used for parallel hybridisations with a Bgpl gene- specific probe (left panel) and a kanamycin-resistant gene, NPTII, specific probe (right panel). A 6.3 kb fragment (arrowhead) showed hybridisation with the Bgp-1 specific probe but not with NPTII probe indicating that it contains the endogenous Bgpl gene. The insertions of antisense constructs in transgenic plants were confirmed by the presence of DNA fragments which hybridised with both Bgpl and NPTII probes, (b) DNA gel blot analysis of 4 individual T x plants showing the ineritance of the antisense gene, (c) RNA gel blot analysis of 3 individual T x plants. The expression of endogenous and antisense Bgpl gene in T x plants. The expression of endogenous and antisense Bgpl gene in T plants was determined using specific probes. The endogenous sense Bgpl transcripts were detected in the flowers of control wild type (WT) untransformed plants, but not in any of T x plants. The expression of the antisense Bgpl gene was detected in the flowers of male sterile T j plants, but not in the untransformed wild type plants. Primary transformants (T 0 ) carrying antisense Bcpl gene were cross-pollinated with wild-type to produce seeds. The T t progenies were grown in the greenhouse. Genomic DNA was extracted from leaf tissues of appropriate plants and digested with Bam HI, which does not cut inside the Bcpl gene. DNA fragments were separated on 0.7% w/v agarose gel (lOμg/lane) and transferred onto nylon membrane. The blots were hybridised with a ^P-labelled probe derived from the Bcpl cDNA clone. Parallel blots were hybridised with a NPTII gene probe. mRNA were isolated directly from flower inflorescences using Daneal Beads. RNA gel blots were prepared as described (Maniatis et al, 1982). ^P-Labelled sense and antisense riboprobes were generated by in vitro transcription from the Bcpl cDNA clone. Figure 13 is a photographic representation of male sterile (MS) Arabidopsis thaliana. (a) Flower inforescences from wild type ( WT) plants. The plants produce elongated seed pods (Sp) resulted from self-pollination. Each seed pod yields 52-68 seeds, (b) Flower inflorescences from male sterile (MS) plants induced by transformation of the Bgpl antisense gene. The male sterility is characterised by short and empty seed pods after self-pollination, (c) and (d) fluorochromatic reaction (FCR) test of pollen viability (Heslop-Harrison et al 1984). The viable pollen is characterised by the presence of bright fluorecence in pollen cytoplasm. Pollen grains from wild type plants showed 99% positive reaction (c), indicating high pollen viability, whereas pollen grains from male sterile plants gave no positive reaction (d), indicating that pollen is non-viable. The Bcpl antisense gene were constructed by inserting the 500 bp cDNA clone Bcpl in the reversed orientation between an anther-specific promoter, Bgpl and nonpaline synthase (nos) sequence. It was then cloned into a binary vector, Bin 19 (Bevan, 1984) and introduced into Arabidopsis thaliana (ecotype Landsberg erectά) using Agrobacterium tumefaciens-media.ted transformation (Nalvekens et al, 1988). The transformants were selected on medium containing kanamycin. Pollen grains from both wild type and transformed plants were stained with fluorescein diacetate and viewed with fluorescnece microscopy under UV excitation (Heslop-Harrison et al, 1984). Figure 14 is a photographic representation showing differential staining of aborted and nonaborted pollen in nondehiscent anthers of male sterile plants using Alexander stain (Alexander, 1969). This stain differentially stains pollen walls (staining green) and pollen protoplasm (staining red). Anthers from wild type (WT) plants contain regular, spherical pollen grains with intensive red staining in the protoplasm. In strong contrast with the fertile pollen from wild type plants, the majority of pollen grains ( >90%) from male sterile (MS) antisense primary transformants show only green staining of pollen walls indicating that the pollen grains are devoid of protoplasm and empty. The remaining grains had degenerated protoplasm as indicated by weak pink staining. Figure 15 is a photographic representation showing light and electron microscopic analyses of mature anthers from male sterile plants showing the abnormalities of pollen grains, (a) Cross-sections of anthers from wild-type (WT) and male sterile antisense primary transformants (MS) shortly before dehiscencing. The majority of pollen grains in the anthers of male sterile plants has no internal protoplasm confirming the observation obtained by Alexander stain in Figure 14. (b) Transmission electron microscopic (TEM) studies of pollen from wild type and antisense male sterile plants. The male sterile pollen was completely empty and only the crushed exines are present, (c) Scanning electron microscopic (SEM) studies of fertile pollen from wild type plants and sterile pollen from antisense plants. Mature flowers were fixed in 2% glutaradehyde and postfixed in 1% osmium tetraxide. After dehydration through an enthanol series, the flowers were embedded in Spur resin and sectioned. For light microscopy, semi-thin sections (lμm) were stained with toluidine blue and mounted. For TEM, ultra-thin sections were stained and viewed following standard procedure. For SEM observation, dehiscencing anthers were mounted on stab and air dried in a desiccator. The samples were observed after gold sputtering. The following is a summary of the SEQ ID NOs referred to in the subject specification. The SEQ ID NOs are defined in full after the bibliography. SUMMARY OF SEQ ID NOs SEQ ID NO. 1 Open reading frame of B. campestris Bgpl SEQ ID NO. 2 Deduced amino acid sequence of SEQ ID NO. 1 SEQ ID NO. 3 Open reading frame of A. thaliana Bgpl SEQ ID NO. 4 Deduced amino acid sequence of SEQ ID NO. 3 SEQ ID NO. 5 Promoter region of B. campestris Bgpl SEQ ID NO. 6 Promoter region of A. thaliana Bgpl SEQ ID NO. 7 B. campestris Bgpl SEQ ID NO. 8 A. thalianaBgpl SEQ ID NO. 9 B. campestris Bgpl modified promoter -767 to -116 SEQ ID NO. 10 Bgpl specific oligonucleotide SEQ ID NO. 11 Bgpl oligonucleotide SEQ ID NO. 12 Bgpl TATA box sequence SEQ ID NO. 13 Consensus Bgpl sequence EXAMPLE 1 CLONING OF BRASSICA Bgpl Construction of genomic library, screening and isolation of the genomic clone Bgpl. A genomic library was prepared from leaf material of Brassica campestris cv. T15. Genomic DNA was isolated according to standard procedures (Murray et al., 1980) and partially digested with Sau 3A Sau 3A fragments were size fractionated on a glycerol gradient (10-40%) by centrifugation at 40,000 rpm overnight. Aliquots of 500μl fractions were taken and diluted 1:2 in TE buffer (lOmM TRJS-HCI,pH8.0; ImM EDTA). DNA from the chosen fractions was then recovered by precipitation with ethanoi and centrifugation at 13,000g for 30 minutes. The resultant 9-23kb fragments were ligated into EMBL3 Bam HI arms (Stratagene). The ligation mix was then packaged into phage using Packagene (Promega Biotec.) to yield the genomic library. The library was plated on LB media at a density of approximately 10 000 plaques per 90mm plate using Escherichia coZ NW2 (Woodcock et al, 1988) as the host strain. Duplicate plaque lifts were performed using Hybond-C extra following the manufacturer's protocol. The filters were hybridized with ^-labelled Bgpl in 2xSSPE, 0.5% w/v Blotto, 1% w/v PEG 20 000, 7% w/v SDS and 250 mg/ml (final volume) denatured Herring sperm DNA at 65 °C. Filters were washed at 65 °C for 30 minutes in 2xSSC, 0.1% w/v SDS and for 15 minutes in 0.2xSSC, 0.1% w/v SDS. Filters were exposed to Kodak X-Omat film overnight at -70 °C. The genomic clone obtained is designated "Bgpl". DNA Sequencing. A series of overlapping deletion clones (Bgpl.1 -Bgpl .7) were generated from the Bgpl 4.2 kb HwdllL genomic fragment by digestion with Exonuclease III and religation. The protocols supplied with the Nested Deletions kit (Pharmacia LKB) were followed. Southern blot analysis demonstrated that Bgpl.l - Bgpl .5 but not Bgpl .6 and Bgpl .7 show homology to Bgpl. Sequencing then commenced using Bgpl.l though Bgpl .5 as templates. Sequencing reaction was performed on double- stranded template according to the T7 polymerase sequencing kit manual (Pharmacia LKB). Both strands were sequenced using T7, SP6 or synthetic primers made to internal sequences. RNA and DNA gel blot analyses. RNA gel blot hybridizations were performed using total RNA (20μg per lane) separated by electrophoresis on f ormaldehyde-agarose gels and blotted onto Hybond- N (Amersham) nylon filters (Maniatis et al., 1982). Filters were prehybridized, hybridized with ^P-labelled oligonucleotide and washed according to the manufacturers specifications (Amersham). DNA gel blots were performed using lOμg of B.campestris DNA per digest separated on 0.8% w/v agarose gels and blotted onto Hybond-N filters following standard protocols (Maniatis et al., 1982). Prehybridization, hybridization with ^P-labelled DNA and washing was again done according to the manufacturer's specifications (Amersham). Primer extension analysis. The transcriptional start point of Bgpl was determined by primer extension analysis performed according to standing procedures (Maniatis et al., 1982). A 15-mer synthetic oligonucleotide of sequence 5 '-CG T1T1 GGCGACCCA-3 ' (SEQ ID NO. 11) complementary to nucleotides 22 - 36 of Bgpl was end-labelled with [g 32 ?] ATP (Amersham) and T4 polynucleotide kinase (Promega Biotech). After annealing and extension of the primer, the products were analysed on a polyacrylamide sequencing gel. Construction of plas ids. The 0.8 kb Pst Ϊ-Hae III DNA fragment (from position - 767 to + 100 including the 0.7 kb 5' flanking region and 100 nucleotides of the 5' untranslated leader sequence of the Bgpl gene), was excised from Bgpl.3, a deletion clone of Bgpl, and ligated to Bluescript ( + ) KS (Stratagene). This fragment was then excised as a Hindlll-Bam HI fragment and inserted into the polylinker of the vector, pBI 101 (Stratagene). This vector is a derivative of the binary vector pBIN 19 (Bevan, 1984) which contains a promoter-less gus gene cassette (Jefferson et al., 1986) fused to the nopaline synthase polyadenylation region. The resulting Bgpl-GUS chimeric construct, designated as pBgpl.2, was mobilized into Agrobacterium tumefaciens strain LB A 4404, by conjugating with a helper plasmid pRK 2013 (Koncz and Schell, 1986). Plant transformation. (i) Tobacco: leaf discs of Nicotiana Tabacum var. Wisconsin 39 were transformed with Agrobacterium tumefaciens essentially as described in Horsch et al (1985). Shoots arising from leaf discs were rooted on MS medium (Gibco Laboratory) containing 1.0 μg/ml IAA, 1.0 μg/ml BAP, 100 μg/mlKanamycin, transferred to soil and grown to flowering in the greenhouse. Arabidopsis thaliana var Landsberg roots were transformed according to Valvekens et al. (1985). Transgenic plants were selected on medium containing 50 μg ml '1 kanamycin. GUS assay. Histochemical GUS assays were performed essentially as described by Jefferson et al. (1987). For histochemical assay, plant materials were placed in the wells of a microtiter plate containing 1 mM X-Glu (5-bromo-4-chloro-3-indolyl- β-D-glucuronic acid, Sigma) in 0.1 M NaP0 4 pH 7.0, 0.1% v/v Triton-X 100 and incubated at 37 °C for 8 to 12 h. In Arabidopsis, the positively stained flowers were processed for cryo- sectioning. The samples were embedded, rapidly frozen in Tissue-Tek OCT compound (Miles Inc., Elkhart, IN) and sectioned at -20 °C using a 2800 Frigocut cryostat (Reicher-Jung, Germany). The developmental stages of anthers were determined by staining the sections with DAPI (Coleman and Goff, 1984). Genomic clone Bgpl is highly homologous to the cDNA clone Bcpl. A genomic clone, designated Bgpl was isolated from Brassica campestrisv- ng cDNA clone Bcpl as a probe. A partial restriction endonuclease site analysis of the llkb genomic fragment in Bgpl resulted in the map presented in Figure 1. Southern blot analysis using Bcpl as a probe revealed that a 4.2kb Hind III fragment from the llkb genomic clone contained the coding region of the gene. This fragment was then subcloned and partially sequenced. A total of 1620bp of DNA was determined, this included the entire sequence of the coding region along with 767bp of 5' flanking sequence. Comparison of the cDNA sequence of Bcpl (Theerakulpisut et al., 1991) with the coding region of genomic clone Bgpl revealed an overall homology of 88%. No introns are present. The sequence of the Bgpl coding region, 767bp of 5' flanking region and 392bp of 3' flanking region is presented in Figure 1. EXAMPLE 2 TISSUE-SPECIFIC EXPRESSION OF Bgpl ENDOGENOUS GENE In order to determine the expression pattern of Bgpl gene, a Bgpl -specific oligonucleotide was synthesized based on the sequence between nucleotides 181 - 201 (5' - GGCTGCTACCGTAACCGATGT - 3' [SEQ ID NO. 10]) (Fig. 1), a region which shows a high level of variability between the two genes, Bgpl and Bcpl. This 21mer oligonucleotide was used to probe a Northern blot containing total RNA isolated from B. campestris pollen, leaf, stem, and flower (minus anther). As a negative control Bcpl DNA was included on the blot to ensure the specificity of the oligonucleotide. Figure 2 shows that the Bgpl -specific oligonucleotide hybridizes to RNA present in pollen but not to RNA present from any other tissue tested. The size of the transcript = 700 nucleotides is approximately the same size as the RNA transcript to which clone Bcpl hybridizes (Theerakulpisut et al., 1991). EXAMPLE 3 Bgpl BELONGS TO A SMALL GENE FAMILY To determine whether the clone Bcpl represents a transcript from a member of a gene f amily, the cDNA insert was used to probe a DNA gel blot of total B.campestris DNA. Figure 3 shows that Bcpl cDNA insert hybridizes to several genomic bands including the 4.2kb HindϊLl fragment representing the Bgpl gene. It is difficult to estimate the gene family copy number from this blot but there are at least two members in the gene family. EXAMPLE 4 DETERMINING THE TRANSCRIPTIONAL START OF Bgpl The transcriptional start point of Bgpl was determined by primer extension analysis. An oligonucleotide was synthesized based on the sequence between nucleotides 22 - 36 (Fig. 1). Figure 4 shows that when this primer was used in extension analysis and the labelled products run next to the sequence of clone Bgpl, a fragment of length 61 nucleotides can be detected. This indicates that the A nucleotide at position 1 (Fig. 1) is the first nucleotide transcribed from the Bgpl gene. Fainter bands are likely to be due to homologous transcripts from other members of the Bcpl gene family. EXAMPLE 5 SEQUENCE ANALYSIS The promoter region of the Bgpl gene contains a TATA box sequence (CAACTATATATAG [SEQ ID NO. 12]) which is located 26 nucleotides upstream of the start of transcription (see Fig. 1). In agreement with the "scanning mechanism" theory (Kozak, 1986), the franslational start of the Bgpl gene is the first ATG codon present in the sequence, which is found 69 nucleotides downstream from the start of transcription (Fig. 1). The putative start codon gives the longest possible open reading frame (357 nucleotides) and its flanking regions match perfectly with the consensus proposed for plant genes of AACAATGGC [SEQ ID NO. 13] (Lutcke et al., 1987). The resulting untranslated leader sequence is characteristically A/T rich (63%). The predicted protein sequence of clone Bgpl is shown under the nucleotide sequence in Fig. 1. The Bgpl protein sequence is very similar to the predicted protein sequence from Bcpl (Theerakulpisut et al., 1991) showing 87.5% identity. A computer search comparing the nucleotide and amino acid sequence of clone Bgpl with the sequences contained in GeriBank, EMBL and NBRF databases revealed no significant homologies. The 5' upstream region of clone Bgpl was examined for homology to the promoter regions of both anther and pollen specific genomic clones. A comparison of the entire 767bp Bgpl 5' region was made with a range of 5' sequences from pollen/anther specific genes (Hamilton et al., 1989; Twell et al., 1989, 1991; Koltunow et al., 1990; Albani et al., 1991a, 1991b). No significant regions of homology were observed. EXAMPLE 6 TRANSFORMATION OF THE FULL LENGTH PROMOTER CONSTRUCT INTO ARABIDOPSIS - HIGH LEVELS OF GUS ACTIVITY PRESENT IN POLLEN AND TAPETUM The histochemical distribution of the GUS activity driven by the 767bp Bgpl 5' region carried by the construct pCB1.2 is illustrated in Figure 5. Figure 5A shows that high levels of GUS activity were present in anthers, but not in petals, sepals, filaments and pistils. No GUS activity was detected in anthers of control untransformed plants. The developmental pattern of Bgpl -promoter activity was also analysed in transgenic plants carrying the construct pCB1.2. In cryosections of developing Arabidopsis anthers containing an intact tapetum, Figures 5B and 5C show that high levels of GUS activity were present in the tapetum, whereas only low levels were detactable histochemically in the pollen at early bicellular stage. In near mature anthers, in which the tapetum had begun to degenerate, Figure 5D shows that high levels of GUS activity were present both in the degenerating tapetum and pollen grains. Figures 5F and 5G show that very high levels of GUS activity were present in mature pollen, but not in other tissues of the anther. Figures 5E and 5H show that tissues of control untransformed anthers and pollen produced no histochemically detectable levels of GUS activity. EXAMPLE 7 TRANSGENIC TOBACCO PLANTS SHOW GUS ACTIVITY IN POLLEN ONLY In transgenic tobacco plants carrying pCB.2, GUS activity was detected in pollen (Figure 51). In addition GUS activity was tested in anther sections taken from flower buds at several developmental stages. In tobacco, flower bud length correlates well with gametophytic development (Koltunow et al., 1990). Sections were taken from flower buds of sizes 3mm (tapetum formation commences), 4mm (tapetum and pollen sacs distinct), 5mm (meiosis begins), 6mm (tapetum large and multinucleate), 7mm, 8mm (meiosis complete) through to 14mm (tapetum shrunken, pollen grains begin to form). No GUS activity was detected in the tapetum at any of these developmental stages. EXAMPLE 8 ANALYSIS OF BGP1 5 • PROMOTER DELETIONS To identify cis-acting elements controlling the temporal and spatial expression pattern of Bgpl a series of 5' deletion clones were created. These constructs, shown in Figure 6, were transferred to Arabidopsis thaliana by Agrobacterium tumefaciens- mediated transformation. GUS activity was analysed on primary transformants. At least 10 individual transformants were analysed for each construct. The GUS expression pattern for each of the constructs is presented alongside each of Figure 6. Deletion of the full length promoter down to -580 (pCB1.3) abolished any detectable GUS expression in the pollen of 87% of the plants tested. Expression in the tapetum of plants carrying pCB1.3 was unaffected. However, if further deletion removed the region between -322 and -580 (pCB1.4), GUS expression in the pollen was restored in all the plants tested. Progressive 5' deletions down to -260 (pCB1.5) and -168 (pCBl.6) gave the same result, GUS expression was observed in both the tapetum and the pollen. The smallest construct tested however, which contained only the 5' region up to position -116, directed GUS expression in the tapetum only. EXAMPLE 9 INDUCING MALE STERILITY IN ARABIDOPSIS BY ANTISENSE Construction of antisense gene A Bcpl antisense gene was constructed by inserting the cDNA clone Bcpl in the reverse orientation between an anther-specific promoter, Bgpl and nopaline synthase (nos) sequence. It was then cloned into the plant transformation vector, Bin 19 (Figure 8). The resulting construct was mobilised to Agrobacterium tumefaciens ram LBA 4404 and introduced into Arabidopsis thaliana var Landsberg using standard procedures (Valvekens et al, 1988). The transgenic plants carrying the antisense construct were selected by Kanamycin resistance. Phenotype modification of the transgenic plants carrying Bcpl antisense construct The transgenic plants were examined for male-fertility in terms of the number of seeds produced following self-pollination. A total of 50 flowers from each of 20 different healthy plants were examined. All the plants produce phenotypically normal flowers. However, the plant produced short siliques typical of male sterile plants (Moffat and Sommerville, 1988) and no seeds were set after selfing (Figure 9). Female-fertility of the transgenic plants The transgenic plants carrying the Bcpl antisense construct were examined for their female-fertility by cross-pollinating with pollen from Wild-type plants. Ten flowers from three transgenic plants were pollinated with Wild-type pollen. All the flowers produced normal elongated siliques following cross-pollination, indicating that female function is normal in these antisense transgenic plants. Pollen morphology in Antisense plants Pollen grains from both Wild-type and antisense plants were examined by scanning electron microscopy for possible alteration of pollen surface structure and morphology. Pollen from five of the antisense plants appeared to be collapsed and shrunken when prepared a similar way to wild-type pollen. Some of the pollen grains showed aberrant exine structure. In one antisense plant, the formation of the fish-net patterned ektexine was irregular, with prominent patches where the ektexine was missing over the pollen surface. In the antisense plants, light and transmission electron microscopic analyses showed that in mature pollen, the internal protoplasmic structure was completely disorganised or empty. Developmental studies showed that tapetal and microspore differentiation was normal until the time of first pollen mitosis. The cytoplasm of the pollen grains then developed mutiple vacuoles, and became disorganised. These data indicate that sterility of the pollen grains sets in at about the time of maximal expression of the gene Bcpl in the pollen grains. While tapetal development appeared normal, the 100% effectiveness of the antisense construct in all 20 plants suggests that expression of Bgpl in the tapetum is vital for normal pollen development. Pollen viability test (FCR test) Pollen grains from Wild-type and antisense plants were examined for viability using the Fluorochromatic Reaction (FCR) test (Heslop-Harrison et al, 1984). Pollen from Wild-type gave 99% positive reaction, indicating high pollen quality, whereas pollen from antisense plants showed no positive FCR staining, indicating that pollen quality has been lost, and membrane integrity has been detrimentally altered. These data show that Bgpl gene is essential for normal pollen development. This is shown by the male sterility induced when the gene is present in antisense RNA version. Bgpl is expressed in both the tapetum and pollen, and down regulation of its expression in the antisense plants clearly shows the importance of the gene product for normal development. EXAMPLE 10 CLONING HOMOLOGOUS GENE FROM ARABIDOPSIS RNA gel blot studies indicated that a gene homologous to B. campestris Bgpl is expressed in Arabidopsis thaliana (Figure 10). The specificity and pattern of expression in anthers of Arabidopsis Bgpl was isolated by screening an Arabidopsis genomic library with the Brassica Bgpl cDNA clone (Figure 11). DNA sequencing studies show that the Arabidopsis Bgpl cDNA genomic clone in 1132 bp, with an ORF of 137 amino acids (compared with 119 in Brassica). The deduced amino acid sequence does not contain introns and encodes an alanine-rich (16%) protein with a relative molecular mass, M,. 14K (compared with 12K Brassica). The nucleotide and deduced amino acid sequences of Bgpl show no homology with other known genes or proteins in the databases. No potential N-glycosylation sites are present in the amino acid sequence. Mouse polyclonal antibodies raised against two synthetic peptides based on hydrophylic regions of the Brassica Bgpl amino acid sequence recognised M,. 11-12 K polypeptides by Western analysis. Accordingly, the results indicated that the Bgpl gene is expressed specifically in tapetum and pollen and encodes a protein of M J .12-14K in both Brassica species and Arabidopsis species. EXAMPLE 11 CONTROL OF ANTHER-SPECIFIC EXPRESSION OF ARABIDOPSIS Bgpl To demonstrate that 5' sequences control Bgpl gene developmental specificity, the Escherichia coliGUS gene was fused with a 0.77 kb upstream fragment (nucleotides - 767 to +100; Xu et al, 1993), containing the start codon and then transformed Arabidopsis plants with the chimaeric Bgpl GUS gene. Several independent transformants were obtained. Each transformant showed GUS enzyme activity in both tapetum and pollen. The pattern of GUS activity in anthers of transgenic plants is consistent with the expression of endogenous Bgpl gene in Brassica and Arabidopsis. Comparison of 5 '-flanking regions of Bgpl from both Brassica and Arabidopsis shows that the two genes share a conserved region of high homology in the 167 nucleotides that lie immediately upstream of the transcriptional initiation site (Figure lib). There is no significant homology between the 5' regions of the two genes beyond this point. Because of the highly conserved pattern of expression of this gene in anthers of the two genera, it was expected that this 167 bp 5' region may be sufficient to direct the normal developmental expression of the genes. To examine this, a chimaeric gene was constructed by fusing the 167 bp fragment with GUS (nucleotides -167 to +100; Xu et al., 1993). The Arabidopsis plants transformed with this construct showed the same pattern of GUS enzyme activity in anthers as those transformed with larger promoter fragments. Since GUS enzyme activity in plants transformed with a truncated 5' fragment appeared to be relatively less than those with the larger fragment, it was decided that the region upstream of the -167 bp may have an enhancer effect for Bgpl gene expression. EXAMPLE 12 ANTISENSE ENfflBITTONOF Bgpl GENE EXPRESSION INDUCES MALE STERILITY The 0.77 kb Bgpl gene regulatory fragment was fused with antisense Bcpl cDNA expression. This chimaeric construct was introduced into Arabidopsis plants and 22 primary transformants (T 0 ) were obtained. The transformants appeared identical to untransformed control plants with respect to growth rate, height, leaf and flower morphology, time of flowering and flower colour (Figure 13). However, 7 of antisense transformants failed to show elongation of siliques, indicating loss of fertility. Microscopic examination of flowers of antisense transformants (T 0 ) showed the presence of defective pollen grains in the anthers, confirming that the effect is specifically on male rather than female fertility. Pollen from anthers of antisense transformants was negative when tested for pollen quality by FCR test (Heslop- Harrison et al., 1984) compared with pollen from anthers of normal plants (Figure 13). Use of Alexander's stain (which indicates the presence or absence of cytoplasm in pollen grains as a measure of sterility) showed that > 90% of pollen in antisense transformants is present as empty exines (green staining), while the remaining grains had cytoplasm (weak pink or red staining) in various stages of degeneration (Figure 14). In contrast, pollen from anthers of normal plants showed densely staining (purple) grains. Sections of anthers were prepared from both transformed and untransformed (normal) plants. Male sterile anthers showed collapsed pollen sacs, and pollen grains without visible cytoplasmic contents (Figure 15a). Rare grains showed some residual cytoplasm that appeared disorganised and lysed (Figure 15a). All other anther tissues and cell types appeared identical to normal anthers. DNA gel blot analysis of the male sterile primary transformants showed that the male sterility phenotype is linked with the presence of the antisense cDNA in their genome (Figure 12a). The presence of the antisense insert was tested both by use of Bgpl cDNA and neomycin phosphotransferase (NPTII) as hybridisation probes. To determine whether the male sterility is a stably inherited trait, antisense transformants were crossed with pollen from normal (untransformed) plants. Normal silique formation and seed set occurred in all cases. These results indicate that antisense transformants are male sterile, their pistils are able to recognise and transmit pollen normally, and female fertility is unaffected. Eight of T x plants were analysed and all inherited the male sterility phenotype. In 4 of 8 ^ plants, the presence of antisense Bgpl gene was further analysed by DNA gel blot analysis (Figure 12b). The male sterile phenotype and presence of antisense insert completely co-segregated. The introduced gene is present in the genomic DNA of the analysed T x plants with male sterile pollen and absent in the genome of T x plants with normal viable pollen. Inheritance of male sterility phenotype is also observed in T 2 generation. The expression of both endogenous and antisense mRNA expressing Bgpl in both primary transformants was studied and male sterile T t plants (Figure 12c). With sense-specific probe, a single mRNA band of approximately 700 bp was detected in flowers of untransformed plants. The presence of sense Bgpl mRNA could not be detected in either primary transformed or T α plants with male sterility phenotype. However, using an antisense-specific probe, a strongly hybridising transcript of approximately 750 bp was detected in flowers of all male sterile transformants. No antisense RNA was detected in control untransformed plants. Thus, the male sterility phenotype is linked with high expression of antisense Bφl mRNA and loss of sense Bcpl mRNA EXAMPLE 13 ANTISENSE TRANSFORMANTS SHOW PROGRAMMED CELLULAR AUTOLYSIS DURING POLLEN DEVELOPMENT In order to define the stage of pollen development when arrest is initiated, thin sections of developing anthers of both normal plants and antisense transformants were prepared. At tetrad and uninucleate microspore stage, both tapetal cells and microspores appeared normal in both types of anthers. This is the stage when tapetum is most active and the exine is completely formed. At the late microspore stage, the microspore cytoplasm showed signs of vacuolation and autolysis (Figure 14) which appeared to be complete before microspore mitosis. This rapid loss of cellular contents ultimately results in complete collapse of the microspores, which appear as empty shells (Figure 15), since the exine remains imaffected. The tapetum appeared normal in both types of anther. This developmental sequence was similar in both primary transformants (T 0 ) and male sterile T j generation. Those skilled in the art will appreciate that the invention described herein is susceptible to variations and modifications other than those specifically described. It is to be imderstood that the invention includes all such variations and modifications. The invention also includes all of the steps, features, compositions and compounds referred to or indicated in this specification, individually or collectively, and any and all combinations of any two or more of said steps or features. REFERENCES: Albani D, Robert LS, Donaldson PE, Altosaar I, Arnison PG, Fabijanski SF (1991a) Plant Mol. Biol. 15: 605-622. Albani D, Altosaar I, Arnison PG, Fabijanski SF (1991b) Plant Mol. Bio. 16: 501- 513. Alexander MP (1969) Stain Technology 44(3): 117-122. Bevan M, (1984) Nucl. Acids Res. 12: 8711-12. Coleman A, Goff LJ (1984) Stain Techol. 60: 145-154. Hamilton DA Bashe DM, Stinson JR, Mascarenhas JP (1989) Sex. Plant Reprod. 2: 208-212. Haseloff J and Gerlach L (1988) Nature 344: 586-591. Heslop-Harrison J, Heslop-Harrison Y, Shivanna (1984) Theor. Appl. Genet. 67;361- 375. Horsch RB, Fry JE, Hoffmann NL, Wallroth M, Eichholtz D, Rogers SG, Fraley RT (1985) Science 227: 1299-1231. Jefferson RA, Burgess SM, Hirsh D (1986) Proc. Natl. Acad. Sci. USA 53:8447-8451. Jefferson RA, Kavanagh TA, Bevan MW (1987) EMBO J. 6: 3901-3907. Koltunow AM, Truettner J, Cox KH, Wallroth M, Goldberg RB (1990) Plant Cell 2: 1201-1224. Koncz C, Schell J (1986) Mol. Gen. Genet. 204: 383-396. Kozak M (1986) Cell 44: 22.3-292. Lutcke HA, Chow KC, Mickel FS, Moss KA, Kern HF, Scheele GA (1987) EMBO J. 6: 43-48. Maniatis T, Fritsch EF, Sambrook J (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory Press, New York. Mascarenhas JP (1988) Anther and pollen expressed genes. In: VermaDPS, Goldberg RB (eds) Temporal and spatial regulation of plant genes. Spriner-Verlag, New York, pp 97-125. Moffatt BA and Sommerville C (1988) Plant Physiol. 86: 1150-1154. Murray HG, Thompson WF (1980) Nucl. Acids Res. 8: 4321-4325. Sambrook et al (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory Press, New York. Theerakulpisut P, Xu HL, Singh MB, Pettitt JM, Knox RB (1991) Plant Cell. 3: 1037-1084. Twell D, Wing RA, Yamaguchi J, McCormick S (1989) Mol. Gen. Genet. 217:240- 245. Twell D, Yamaguchi J, Wing RA, Ushiba J, McCormick S (1991) Genes Dev. 5:496- 507. Valvekens D, Van Montagu M, Van ijsebettens M (1988) Proc. Nail. Acad. Sci. 85: 5536-5540. Woodcock DM, Crowther M, Diver WD, Graham M, Bateman C, Baker DJ, Smith SS (1988) Nucl. Acids Res. 16; 4465-4482. Xu H (1992) PhD Thesis, University of Melbourne. Xu H, Davies SP, Kwan BVH, O'Brien AP, Singh, MB, Knox RB (1993) Mol. Gen. Genet. 239: 58-65. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANT: (countries other than US) THE UNIVERSITY OF MELBOURNE (US only) KNOX, RB; SINGH, MB; and XU, H. (ii) TITLE OF INVENTION: DEVELOPMENTAL REGULATION IN ANTHER TISSUE OF PLANTS (iii) NUMBER OF SEQUENCES: 13 (iv) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: DAVIES COLLISON CAVE (B) STREET: 1 LITTLE COLLINS STREET (C) CITY: MELBOURNE (D) STATE: VICTORIA (E) COUNTRY: AUSTRALIA (F) ZIP: 3000 (v) COMPUTERREADABLEFORM: (A) MEDIUM TYPE: Floppy disk (B) COMPUTER: IBM PC compatible (C) OPERATING SYSTEM: PC-DOS/MS-DOS (D) SOFTWARE: Patentln Release #1.0, Version #1.25 (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: AU PCT INTERNATIONAL (B) FILING DATE: 15-DEC-1993 (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: AU PL6400 (B) FILING DATE: 16-DEC-1992 (viii) ATTORNEY/AGENT INFORMATION: (A) NAME: SLATTERY, JOHN M (C) REFERENCE/DOCKET NUMBER: EJH/JMS/EK (ix) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (613) 254 2777 (B) TELEFAX: (613) 254 2770 (2) INFORMATION FOR SEQ ID NO:l: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 357 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..357 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: ATG GGT CGC CAA AAC GCT GTC GTA GTT TTT GGC CTT GTG TTC TTG GCC 48 Met Gly Arg Gin Asn Ala Val Val Val Phe Gly Leu Val Phe Leu Ala 1 5 10 15 ATC CTT GGC CTC GCC GCA GCT GCC TCC TCT CCG TCT CCT TCA GCG TCA 96 lie Leu Gly Leu Ala Ala Ala Ala Ser Ser Pro Ser Pro Ser Ala Ser 20 25 30 CCC TCC AAA GCT CCG GCT GCT ACC GTA ACC GAT GTC GAA GCT CCA GTG 144 Pro Ser Lys Ala Pro Ala Ala Thr Val Thr Asp Val Glu Ala Pro Val 35 40 45 AGC GAG GAC ACC ATT GGA ACC ACC GAT GAC GAT GCA GCT GCT TCT CCA 192 Ser Glu Asp Thr He Gly Thr Thr Asp Asp Asp Ala Ala Ala Ser Pro 50 55 60 GGT GAT GGT GAC GTA GCT GTG GCT GGT CCT CTA GGA AGT GAC TCC TCC 240 Gly Asp Gly Asp Val Ala Val Ala Gly Pro Leu Gly Ser Asp Ser Ser 65 70 75 80 TAC GGT AGT AAT GGA CCT TCA CCT TCT ACT GAT GCT GCT GAC AGC GGC 288 Tyr Gly Ser Asn Gly Pro Ser Pro Ser Thr Asp Ala Ala Asp Ser Gly 85 90 95 GCG CCT GCT CTT GGC GTC TCT GCG GTC TTC GTT GGT GTT GCA TCC ATC 336 Ala Pro Ala Leu Gly Val Ser Ala Val Phe Val Gly Val Ala Ser He 100 105 110 GCC GGT TCT TTC TTG TTT CTC 357 Ala Gly Ser Phe Leu Phe Leu 115 (2) INFORMATION FOR SEQ ID NO:2: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 119 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: Met Gly Arg Gin Asn Ala Val Val Val Phe Gly Leu Val Phe Leu Ala 1 5 10 15 He Leu Gly Leu Ala Ala Ala Ala Ser Ser Pro Ser Pro Ser Ala Ser 20 25 30 Pro Ser Lys Ala Pro Ala Ala Thr Val Thr Asp Val Glu Ala Pro Val 35 40 45 Ser Glu Asp Thr He Gly Thr Thr Asp Asp Asp Ala Ala Ala Ser Pro 50 55 60 Gly Asp Gly Asp Val Ala Val Ala Gly Pro Leu Gly Ser Asp Ser Ser 65 70 75 80 Tyr Gly Ser Asn Gly Pro Ser Pro Ser Thr Asp Ala Ala Asp Ser Gly 85 90 95 Ala Pro Ala Leu Gly Val Ser Ala Val Phe Val Gly Val Ala Ser He 100 105 110 Ala Gly Ser Phe Leu Phe Leu 115 (2) INFORMATION FOR SEQ ID NO:3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 411 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (ix) FEATURE: (A) NAME/KEY: CDS (B) LOCATION: 1..411 (xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: ATG GGT CGC CAA AAC ATT GTC GTC GTG GTT GCC CTC GTC TTC ATC CGG 48 Met Gly Arg Gin Asn He Val Val Val Val Ala Leu Val Phe He Arg 1 5 10 15 ATC ATT GGC CTT GCC GCA GCT GCC TCC TCT CCA TCT CCT TCA GCG TCT 96 He He Gly Leu Ala Ala Ala Ala Ser Ser Pro Ser Pro Ser Ala Ser 20 25 30 CCC TCC AAA GCT CCA GCT GCC TCC AAA ACC GAT CAT GTC GAG GCT CCA 144 Pro Ser Lys Ala Pro Ala Ala Ser Lys Thr Asp His Val Glu Ala Pro 35 40 45 GTC ACC GAT GAC CAA ATC GGA ACC ACC GAT GAC GAT GCA GCT CCT ACT 192 Val Thr Asp Asp Gin He Gly Thr Thr Asp Asp Asp Ala Ala Pro Thr 50 55 60 CCT GGT GAC GGT GAC GTT GCA GTG GCT GGT CCT CTA GGA AGT GAC TCC 240 Pro Gly Asp Gly Asp Val Ala Val Ala Gly Pro Leu Gly Ser Asp Ser 65 70 75 80 TCG TAC GAC AAT GCC GCT ACA GGC TCT GCT GAT TCT GCC AAA AGC GGT 288 Ser Tyr Asp Asn Ala Ala Thr Gly Ser Ala Asp Ser Ala Lys Ser Gly 85 90 95 GCG GCA GCT CTT GGC GTC TCT GCG GTC GTC GTT GGT GTT ACA TCA TTG 336 Ala Ala Ala Leu Gly Val Ser Ala Val Val Val Gly Val Thr Ser Leu 100 105 110 CTG GTT CTT TCT TGT TAC TCA AGT TGG GCA TTG TTT TAT GAT AAG AAG 384 Leu Val Leu Ser Cys Tyr Ser Ser Trp Ala Leu Phe Tyr Asp Lys Lys 115 120 125 GTT ATT TTA AAC GAA GAT TAT TAT ATG 411 Val He Leu Asn Glu Asp Tyr Tyr Met 130 135 (2) INFORMATION FOR SEQ ID NO:4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 137 amino acids (B) TYPE: amino acid (D) TOPOLOGY: linear (ii) MOLECULE TYPE: protein (xi) SEQUENCE DESCRIPTION: SEQ ID NO: : Met Gly Arg Gin Asn He Val Val Val Val Ala Leu Val Phe He Arg 1 5 10 15 He He Gly Leu Ala Ala Ala Ala Ser Ser Pro Ser Pro Ser Ala Ser 20 25 30 Pro Ser Lys Ala Pro Ala Ala Ser Lys Thr Asp His Val Glu Ala Pro 35 40 45 Val Thr Asp Asp Gin He Gly Thr Thr Asp Asp Asp Ala Ala Pro Thr 50 55 60 Pro Gly Asp Gly Asp Val Ala Val Ala Gly Pro Leu Gly Ser Asp Ser 65 70 75 80 Ser Tyr Asp Asn Ala Ala Thr Gly Ser Ala Asp Ser Ala Lys Ser Gly 85 90 95 Ala Ala Ala Leu Gly Val Ser Ala Val Val Val Gly Val Thr Ser Leu 100 105 110 Leu Val Leu Ser Cys Tyr Ser Ser Trp Ala Leu Phe Tyr Asp Lys Lys 115 120 125 Val He Leu Asn Glu Asp Tyr Tyr Met 130 135 (2) INFORMATION FOR SEQ ID NO:5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 838 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: TATCATTCCT TTAATTTCAA GGAATTATAG AACAAAAAAT GTTCTTTATA AAAATTAAGA 60 AGGAACAAGG GATTCATTCC TACTATTCTG TTCTTGGTCA TTATTTTCCT CTTCATTCAT 120 ATTGTTTCTT TAATTGTTAC CAATTAGAAC TTTAACGAAT AAATAGTTAA TTCGTATTAT 180 GAGATTTACA CAATTCTTAT TCACTCAATT TGGAGTTTTA AAGATTTTTT AAAAGATTTA 240 TGGTGGGAAC CTTCTTCTTT TCTTATTTAT CATGATGATG ATAACCTTCC CAGCAGAATT 300 ATTCTTAGAA CTTTTTTTCA CATTTAGGTA TCCATGCCTA AGTAAGGCTT AGTTAAAGAT 360 GTTTTATAAA CTTTGATCAA AATATTCATT CAATTAATTT GAGCTTCAAC TATAAATTGT 420 TGTATGCATT CGTTTTAGCC TGTAAGATAT CAGACATTCA CGTTTCGATA AACAAGTATA 480 TAAATAATAT GAATATTGTA CATTCATTTT ATTCGGTTCA TCAACCAAAA AAAATAAAAA 540 TAAATATTCG TATTCATCTA TGCTTTGGCA TGGTCCGTTC TTTTTTCTTG ATTGGCTCGT 600 TACCATTCAA AAATATATAC CTTAGCAAAC CCATTTTTAG ACATTCCAGT TGATCTACAT 660 TAGATTGAAC GGTATTCCTC CTACGTAGTA AGAACGTTTT CTATTTTTCT TTGTTTCAGT 720 CATACAACAC AACTATATAT ACACAGCAAC CCCATCTCCT CTCCAATCAT CACAATCTCT 780 AACGTTAAAC CCTAAGACAA ACTAAAAGAG AGCTACGTAC AAGGAGACAG AGAGAAGA 838 (2) INFORMATION FOR SEQ ID NO:6: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 496 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: AAAAGCGAGA AGAAGAAGTC TGGAAGATTT GAGAGCTTAA AGTGGTCGAG TGTAAAACCC 60 TAACTCGCTG TTGATGGCAG AATCGTAAAT CGGAATTGAT TCATGGGCCT AACAAGACGT 120 TTGGGCTTAT GGGTTTAAAG CCCATCTGAT ATAAGATGAA TAGAATGTTC ATGGCAATAC 180 TATCATAATT TGGTTCTTTA ATAAGACACT CGTTAATACG ACGACGATTT GAAGTTGAAC 240 GAATGTTTTC ATATTCATTC GCATGTTCAC CAATCAAAAT CTATATCTGA ACAAGTCCAT 300 TTTTAGGTAC TCCAGTAGAT TTACATTGGA TTGTAAGGTA ATCCTACATC TTAGTTCACG 360 TTTTCTATTT TTGGTCTTGT CACTAAACAC AACTATATAT ACATATCAAA CTCATCTTCG 420 GAAATCATCA CAATCAATAA ACCTCAAACC CTAAAATAAA TTAAACGAGT TCTACGTAAG 480 AAGGAGAGAG AGAAGA 496 (2) INFORMATION FOR SEQ ID NO:7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1621 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: TATCATTCCT TTAATTTCAA GGAATTATAG AACAAAAAAT GTTCTTTATA AAAATTAAGA 60 AGGAACAAGG GATTCATTCC TACTATTCTG TTCTTGGTCA TTATTTTCCT CTTCATTCAT 120 ATTGTTTCTT TAATTGTTAC CAATTAGAAC TTTAACGAAT AAATAGTTAA TTCGTATTAT 180 GAGATTTACA CAATTCTTAT TCACTCAATT TGGAGTTTTA AAGATTTTTT AAAAGATTTA 240 TGGTGGGAAC CTTCTTCTTT TCTTATTTAT CATGATGATG ATAACCTTCC CAGCAGAATT 300 ATTCTTAGAA CTTTTTTTCA CATTTAGGTA TCCATGCCTA AGTAAGGCTT AGTTAAAGAT 360 GTTTTATAAA CTTTGATCAA AATATTCATT CAATTAATTT GAGCTTCAAC TATAAATTGT 420 TGTATGCATT CGTTTTAGCC TGTAAGATAT CAGACATTCA CGTTTCGATA AACAAGTATA 480 TAAATAATAT GAATATTGTA CATTCATTTT ATTCGGTTCA TCAACCAAAA AAAATAAAAA 540 TAAATATTCG TATTCATCTA TGCTTTGGCA TGGTCCGTTC TTTTTTCTTG ATTGGCTCGT 600 TACCATTCAA AAATATATAC CTTAGCAAAC CCATTTTTAG ACATTCCAGT TGATCTACAT 660 TAGATTGAAC GGTATTCCTC CTACGTAGTA AGAACGTTTT CTATTTTTCT TTGTTTCAGT 720 CATACAACAC AACTATATAT ACACAGCAAC CCCATCTCCT CTCCAATCAT CACAATCTCT 780 AACGTTAAAC CCTAAGACAA ACTAAAAGAG AGCTACGTAC AAGGAGACAG AGAGAAGAAT 840 GGGTCGCCAA AACGCTGTCG TAGTTTTTGG CCTTGTGTTC TTGGCCATCC TTGGCCTCGC 900 CGCAGCTGCC TCCTCTCCGT CTCCTTCAGC GTCACCCTCC AAAGCTCCGG CTGCTACCGT 960 AACCGATGTC GAAGCTCCAG TGAGCGAGGA CACCATTGGA ACCACCGATG ACGATGCAGC 1020 TGCTTCTCCA GGTGATGGTG ACGTAGCTGT GGCTGGTCCT CTAGGAAGTG ACTCCTCCTA 1080 CGGTAGTAAT GGACCTTCAC CTTCTACTGA TGCTGCTGAC AGCGGCGCGC CTGCTCTTGG 1140 CGTCTCTGCG GTCTTCGTTG GTGTTGCATC CATCGCCGGT TCTTTCTTGT TTCTCTGAGG 1200 TGTGTATTAT CATGAGAAGA TTATTCTGAC TGAAGACTAT TAATATGTAT GGATGATTGT 1260 GATGGTCGTG TTGTAATATG TTTCTCCTTT ATTGTGAGAA ACGATGTTTT GCTAATAAAA 1320 CTGAAAAAAA AAACGAAAAT TTCCTCTAGC CAAGGATAAA ATGCCGGAAT TGCGGATTAA 1380 ATAGTACTAT TCAATCCTTT CATGTTTTCG AGATACAAAA ATACATATTA ATCAGGTAGA 1440 GCCGTAGAAG TCCGTAACCA CTGGATACAA TCTTTTTCGT AGTAAGAAAG AAAGTACAAT 1500 CTTATTCTAA ATGCATGTGT TTGATAGATT ATGGAACGGT GAGAAGGGCA TTGATTATGG 1560 ' GAGTTATGAT CGAAGATACA CACGATACCA TCTTTTTAGG TATAGCTTCT TCTTCTATAA 1620 A 1621 (2) INFORMATION FOR SEQ ID NO:8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1132 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:8: AAAAGCGAGA AGAAGAAGTC TGGAAGATTT GAGAGCTTAA AGTGGTCGAG TGTAAAACCC 60 TAACTCGCTG TTGATGGCAG AATCGTAAAT CGGAATTGAT TCATGGGCCT AACAAGACGT 120 TTGGGCTTAT GGGTTTAAAG CCCATCTGAT ATAAGATGAA TAGAATGTTC ATGGCAATAC 180 TATCATAATT TGGTTCTTTA ATAAGACACT CGTTAATACG ACGACGATTT GAAGTTGAAC 240 GAATGTTTTC ATATTCATTC GCATGTTCAC CAATCAAAAT CTATATCTGA ACAAGTCCAT 300 TTTTAGGTAC TCCAGTAGAT TTACATTGGA TTGTAAGGTA ATCCTACATC TTAGTTCACG 360 TTTTCTATTT TTGGTCTTGT CACTAAACAC AACTATATAT ACATATCAAA CTCATCTTCG 420 GAAATCATCA CAATCAATAA ACCTCAAACC CTAAAATAAA TTAAACGAGT TCTACGTAAG 480 AAGGAGAGAG AGAAGAATGG GTCGCCAAAA CATTGTCGTC GTGGTTGCCC TCGTCTTCAT 540 CCGGATCATT GGCCTTGCCG CAGCTGCCTC CTCTCCATCT CCTTCAGCGT CTCCCTCCAA 600 AGCTCCAGCT GCCTCCAAAA CCGATCATGT CGAGGCTCCA GTCACCGATG ACCAAATCGG 660 AACCACCGAT GACGATGCAG CTCCTACTCC TGGTGACGGT GACGTTGCAG TGGCTGGTCC 720 TCTAGGAAGT GACTCCTCGT ACGACAATGC CGCTACAGGC TCTGCTGATT CTGCCAAAAG 780 CGGTGCGGCA GCTCTTGGCG TCTCTGCGGT CGTCGTTGGT GTTACATCAT TGCTGGTTCT 840 TTCTTGTTAC TCAAGTTGGG CATTGTTTTA TGATAAGAAG GTTATTTTAA ACGAAGATTA 900 TTATATGTAA GGATGATTGT GATGATCCGT TGACCTGCAG GTCGACCCAG ATCCGCCTAC 960 CTTTCACGAG TTGCGCAGTT TGTCTGCAAG ACTCTATGAG AAGCTGATAA GAGATAAGTT 1020 TGCTCAACAT CTTCTCGGGC ATAAGTCCGG ACACCATGGC ATCACAGTAT CGAGATGACA 1080 GAGGCAGGGA GTGGGACAAA ATTGAAATCA AATGATCGAT TTTATTTTGG CT 1132 (2) INFORMATION FOR SEQ ID NO:9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 652 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: DNA (genomic) (xi) SEQUENCE DESCRIPTION: SEQ ID NO:9: TATCATTCCT TTAATTTCAA GGAATTATAG AACAAAAAAT GTTCTTTATA AAAATTAAGA 60 AGGAACAAGG GATTCATTCC TACTATTCTG TTCTTGGTCA TTATTTTCCT CTTCATTCAT 120 ATTGTTTCTT TAATTGTTAC CAATTAGAAC TTTAACGAAT AAATAGTTAA TTCGTATTAT 180 GAGATTTACA CAATTCTTAT TCACTCAATT TGGAGTTTTA AAGATTTTTT AAAAGATTTA 240 TGGTGGGAAC CTTCTTCTTT TCTTATTTAT CATGATGATG ATAACCTTCC CAGCAGAATT 300 ATTCTTAGAA CTTTTTTTCA CATTTAGGTA TCCATGCCTA AGTAAGGCTT AGTTAAAGAT 360 GTTTTATAAA CTTTGATCAA AATATTCATT CAATTAATTT GAGCTTCAAC TATAAATTGT 420 TGTATGCATT CGTTTTAGCC TGTAAGATAT CAGACATTCA CGTTTCGATA AACAAGTATA 480 TAAATAATAT GAATATTGTA CATTCATTTT ATTCGGTTCA TCAACCAAAA AAAATAAAAA 540 TAAATATTCG TATTCATCTA TGCTTTGGCA TGGTCCGTTC TTTTTTCTTG ATTGGCTCGT 600 TACCATTCAA AAATATATAC CTTAGCAAAC CCATTTTTAG ACATTCCAGT TG 652 (2) INFORMATION FOR SEQ ID NO:10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 21 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: Oligonucleotide DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:10: GGCTGCTACC GTAACCGATG T 21 (2) INFORMATION FOR SEQ ID NO:11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 15 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: Oligonucleotide DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:ll: CGTTTTGGCG ACCCA 15 (2) INFORMATION FOR SEQ ID NO:12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 13 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: Oligonucleotide DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:12: CAACTATATA TAG 13 (2) INFORMATION FOR SEQ ID NO:13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: single (D) TOPOLOGY: linear (ii) MOLECULE TYPE: Oligonucleotide DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO:13: AACAATGGC

Claims: CLAIMS: 1. A genomic DNA isolate comprising: (i) all or part of a gene or related genetic sequence preferentially expressed in anther tissue of a plant and substantially not expressed in non-anther tissue; and (ii) an open reading frame having a nucleotide sequence as set forth in SEQ ID NO. 1 or having at least 20% similarity thereto. 2. A genomic DNA isolate according to claim 1 wherein the plant is a dicotyledonous plant. 3. A genomic DNA isolate according to claim 2 wherein the plant is a Brassica species, Arabidopsis species or Nicotiana species. 4. A genomic DNA isolate according to claim 3 wherein the plant is Brassica campestris and the nucleotide sequence of its open reading frame is as set forth in SEQ ID NO. 1. 5. A genomic DNA isolate according to claim 3 wherein the plant is Arabidopsis thaliana and the nucleotide sequence of its open reading frame is as set forth in SEQ ID NO. 2. 6. A genomic DNA isolate according to claim 1 further comprising a promoter region 5' to the open reading frame, wherein said promoter region: (i) is capable of directing expression in tapetum and/or pollen tissue; and (ii) comprises a nucleotide sequence as set forth in SEQ ID NO. 3 or having at least 20% similarity to all or part thereof. 7. A genomic DNA isolate according to claim 6 comprising a nucleotide sequence as set forth in SEQ ID NO. 3. 8. A genomic DNA isolate according to claim 6 comprising a nucleotide sequence as set forth in SEQ ID NO. 4. 9. A genomic DNA isolate comprising: (i) all or part of a gene or related genetic sequence preferentially expressed in anther tissue of a plant and substantially not expressed in non-anther tissue; (ii) a promoter region capable of directing expression in tapetum and/or pollen tissue; (iii) a nucleotide sequence substantially as set forth in SEQ ID NO. 5 or having at least 20% similarity to all or part thereof. 10. A genomic DNA isolate according to claim 9 further comprising: (iv) a nucleotide sequence which is capable of hybridising under low stringency conditions to all or part of a nucleotide sequence substantially complementary to SEQ ID NO. 5. 11. A genomic DNA isolate according to claim 10 comprising a nucleotide sequence as set forth in SEQ ID NO. 5. 12. A genomic DNA isolate according to claim 10 comprising a nucleotide sequence as set forth in SEQ ID NO. 6. 13. An isolated nucleic acid molecule capable of hybridising under low stringency conditions to the genomic DNA isolate according to claim 1 or 4 or 5. 14. An isolated nucleic acid molecule according to claim 13 wherein the nucleic acid molecule is a complementary strand of all or part of SEQ ID NO. 1 or SEQ ID NO. 2. 15. An isolated nucleic acid molecule according to claim 14 in the form of an oligonucleotide. 16. A ribozyme comprising a hybridising region and a catalytic region wherein the hybridising region is capable of hybridising to at least part of a target mRNA sequence transcribed from a genomic DNA isolate according to claim 1 or 4 or 5 wherein the catalytic region is capable of cleaving said target mRNA thereby substantially down regulating expression of said genomic DNA isolate. 17. A ribozyme according to claim 16 wherein in use, said ribozyme renders a target plant substantially male sterile. 18. A genetic construct comprising a promoter region capable of directing expression of a nucleotide sequence when operably linked downstream thereof in tapetum and /or pollen tissue wherein said promoter region comprises a nucleotide sequence substantially as set forth in SEQ ID NO.3 or having at least 20% similarity to all or part thereof. 19. A genetic construct according to claim 18 wherein the promoter region comprises a nucleotide sequence substantially as set forth in SEQ ID NO. 3. 20. A genetic construct according to claim 18 wherein the promoter region comprises a nucleotide sequence substantially as set forth in SEQ ID NO. 4. 21. A genetic construct according to claim 18 or 19 or 20 comprising at least one unique restriction endonuclease site in a region 3' of the promoter region to permit insertion of an operably linked nucleotide sequence downstream of said promoter region. 22. A genetic construct according to claim 18 further comprising one or more regulatory regions capable of controlling operation of said promoter region. 23. A genetic construct according to claim 18 wherein the nucleotide sequence downstream of said promoter region is capable of inducing an infertile pollen grain or a pollen grain incapable of maturation. 24. A genetic construct according to claim 18 wherein the nucleotide sequence downstream of said promoter is all or part of Bcpl or Bgpl in reverse orientation relative the promoter. 25. A genetic construct comprising: (i) a promoter region capable of directing expression of a nucleotide sequence when operably linked downstream thereof in tapetum and/or pollen tissue; and (ii) said promoter being capable of hybridising under low stringency conditions to a complementary strand of SEQ ID NO. 3. 26. A genetic construct according to claim 25 wherein the promoter region comprises a nucleotide sequence substantially as set forth in SEQ ID NO. 3. 27. A genetic construct according to claim 25 wherein the promoter region comprises a nucleotide sequence substantially as set forth in SEQ ID NO. 4. 28. A genetic construct according to claim 25 comprising at least one unique restriction endonuclease site in a region 3' of the promoter to permit insertion of an operably linked nucleotide sequence downstream of said promoter region. 29. A genetic construct according to claim 25 further comprising one or more regulatory regions capable of controlling operation of said promoter region. 30. A genetic construct according to claim 25 wherein the nucleotide sequence downstream of said promoter region is capable of inducing an infertile pollen grain or a pollen grain incapable of maturation. 31. A genetic construct according to claim 25 wherein the nucleotide sequence downstream of said promoter region is all or part of Bcpl or Bgpl in reverse orientation relative the promoter. 32. A method for generating male sterile plants, said method comprising transforming a cell or group of cells of said plant with the genetic construct according to claim 18 or 25 wherein said genetic construct directs expression of a nucleotide sequence having a deleterious effect on tapetum and/ or pollen tissue, regenerating a transgenic plant from said transformed cells and growing and/or maintaining said transgenic plant under conditions to thereby having a deleterious effect on said tapetum and/or pollen tissue resulting in said plant being substantially male sterile. 33. A method according to claim 32 wherein the nucleotide sequence having a deleterious effect in antisense to all or part of SEQ ID NO. 1 or SEQ ID NO. 2. 34. A method according to claim 32 wherein the nucleotide sequence having a deleterious effect is a ribozyme comprising a hybridising region and a catalytic region wherein the hybridising is capable of hybridising to at least part of a target mRNA sequence transcribed from a genomic DNA isolate according to claim 1 or 4 or 5 wherein the catalytic region is capable of cleaving said target mRNA thereby substantially down regulating expression of said genomic DNA isolate. 35. A transgenic plant comprising a genetic construct capable of substantially down regulating expression of SEQ ID NO. 1 or a nucleotide sequence having at least 20% similarity to all or part thereof such that said transgenic plant is male sterile. 36. A transgenic plant according to claim 35 wherein said plant is a Brassica species, Arabidopsis species or Nicotiana species. 37. A method for generating male sterile plants, said method comprising introducing into a cell or group of cells of said plant a genetic construct comprising all or part of a Bgpl gene, said Bgpl gene having a nucleotide sequence substantially similar to an endogenous Bgpl of the plant and then regenerating a plant from said cells. 38. A method according to claim 37 wherein the introduced Bgpl gene does not include a promoter region. 39. A method according to claim 37 or 38 wherein the introduced Bgpl gene comprises a nucleotide sequence as set forth in SEQ ID NO. 1 or 2. 40. An antisense genetic construct comprising SEQ ID NO. 1 or SEQ ID NO. 3 in reverse orientation. 41. An antisense genetic construct comprising a part of SEQ ID NO. 1 or SEQ ID NO. 3 in reverse orientation. 42. A hybrid genetic sequence comprising a ribozyme according to claim 16 or 17 and an anisense genetic construct according to claim 40 or 41.

Inventors: KNOX ROBERT BRUCE, SINGH MOHAN BIR, XU HUILING, KNOX, ROBERT, BRUCE, SINGH, MOHAN, BIR, XU, HUILING
Applicants: KNOX ROBERT BRUCE, SINGH MOHAN BIR, UNIV MELBOURNE, XU HUILING, KNOX, ROBERT, BRUCE, SINGH, MOHAN, BIR, THE UNIVERSITY OF MELBOURNE, XU, HUILING
Application year: 1993
Main classification: C12N15
IPC codes: A01H1, C07K14, C12N15